Sertraline HCL Tablets
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Modification P00002 to invoke Option Year 1 effective June 28, 2022 through June 27, 2023.
Amendment 0004 SPE2D220R0067 is issued to change the solicitation date to reflect August 27, 2020 at 3:00 PM EDT.
Amendment 0003 SPE2D220R0067 is issued to incorporate updated and addeded clauses and provision into the solicitation.
Amendment 0002 SPE2D220R0067 is issued to extend the closing date until August 13, 2020 at 3:00 PM EDT.
Amendment 0001 SPE2D220R0067 is issued to incorporate the following tax provision and clause into the solicitation:
FAR 52.229-11 Tax on Certain Foreign Procurements—Notice and Representation.
FAR 52.229-12 Tax on Certain Foreign Procurements.
Solicitation for Sertraline HCL Tablets SPE2D2-20-R-0067